Alpha Cognition Inc Alpha Cognition Inc

Alpha Cognition Inc

ACOG

Rang în acțiuni #20318
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Preț acțiune
$8.26
Capitalizare de piață
$128.29M
Schimbare (1 zi)
0.85%
Schimbare (1 an)
64.21%
Țară
US
Tranzacționează Alpha Cognition Inc (ACOG)

Categorie

Healthcare
EPS pentru Alpha Cognition Inc (ACOG)
EPS la data de June 2026 TTM: $-0.40
Conform celor mai recente rapoarte financiare și prețului acțiunilor Alpha Cognition Inc, EPS-ul actual al companiei (TTM) este $-0.40. La sfârșitul anului 2022, compania avea un EPS de $-0.18 o scădere comparativ cu EPS-ului din 2021, care a fost de $-0.37.
Istoricul EPS pentru Alpha Cognition Inc din 2018 până în 2026
EPS la sfârșitul fiecărui an
An EPS Schimbă
2026 (TTM) $-0.40 166.67%
2023 $-0.15 -16.67%
2022 $-0.18 -51.35%
2021 $-0.37 -61.46%
2020 $-0.96 357.14%
2019 $-0.21 672.06%
2018 $-0.03 0.00%
EPS pentru companii similare sau concurente
Companie EPS Diferență EPS Țara
$17.32 -4,430.00%
US
$-7.98 1,895.00%
US
$-5.29 1,222.50%
AU
- -
CH
$27.74 -7,035.00%
NL